Why are researchers studying the very earliest stages of cancer? How will artificial intelligence change how we understand and treat cancer? Which chance discovery in a Cambridge lab led to a revolutionary new cancer drug? And how will the new Cambridge Cancer Research Hospital (CCRH) change the story of cancer?
These are some of the questions at the heart of a new campaign launched this week by the University of Cambridge in partnership with Cambridge University Hospitals (CUH) NHS Foundation Trust and the Cancer Research UK Cambridge Centre.
The campaign starts with an exclusive insight into the public’s concerns around cancer (opens in a new tab) and views on cancer research.
There is also a new online cancer hub, with a range of articles including how the University is helping to end death and disease caused by cancer, the importance of early detection, making treatments more effective through personalised, precision approaches, and how patients are involved in this work.
Throughout July, more content will be published including researcher profiles, the story behind the transformative cancer drug olaparib and insights into artificial intelligence in cancer research and care.
Visit the University's cancer hub, (opens in a new tab) which also includes a spotlight on Cambridge Cancer Research Hospital. (opens in a new tab)
Look out, too, for more content from the wider Cambridge cancer community on social media by following #ChangingTheStoryOfCancer – and join us by sharing your own stories, too.
You can read the full story on the Cambridge University website here (opens in a new tab) (opens in a new tab)